Tuberculosis outbreak among Rastafarians in Birmingham

The prospective evaluation of the TB strain typing service in England: a mixed methods study.

Thorax·2015

Lung clearance index: evidence for use in clinical trials in cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2013

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.

Gene therapy·2013

Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.

Gene therapy·2011

Pneumothorax in cystic fibrosis: prevalence and outcomes in Scotland.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2010

Sputum and serum calprotectin are useful biomarkers during CF exacerbation.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2010

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Understanding and Addressing Delays in Endocrine Surgery: Insights From a Mixed-Methods Study and a Pilot Educational Intervention.

Journal of surgical oncology·2026

Tirzepatide and reduced risk of pulmonary embolism and deep vein thrombosis: a multicenter U.S. cohort study.

Frontiers in endocrinology·2026

The impact of question order on surveillance of nicotine pouch and smokeless tobacco use among adults in the United States.

Preventive medicine reports·2026

Heated tobacco product awareness and use following New Zealand's excise tax reduction on these products: A cross-sectional survey of adults who smoke tobacco.

Preventive medicine reports·2026

Advances in drug addiction research using <i>Caenorhabditis elegans</i>: behavioral and molecular mechanisms.

Frontiers in cell and developmental biology·2026

Erratum: A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives [Corrigendum].

Diabetes, metabolic syndrome and obesity : targets and therapy·2026

Related Experiment Videos

Tuberculosis outbreak among Rastafarians in Birmingham

Related Concept Videos

The prospective evaluation of the TB strain typing service in England: a mixed methods study.

Lung clearance index: evidence for use in clinical trials in cystic fibrosis.

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.

Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.

Pneumothorax in cystic fibrosis: prevalence and outcomes in Scotland.

Sputum and serum calprotectin are useful biomarkers during CF exacerbation.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Understanding and Addressing Delays in Endocrine Surgery: Insights From a Mixed-Methods Study and a Pilot Educational Intervention.

Tirzepatide and reduced risk of pulmonary embolism and deep vein thrombosis: a multicenter U.S. cohort study.

The impact of question order on surveillance of nicotine pouch and smokeless tobacco use among adults in the United States.

Heated tobacco product awareness and use following New Zealand's excise tax reduction on these products: A cross-sectional survey of adults who smoke tobacco.

Advances in drug addiction research using <i>Caenorhabditis elegans</i>: behavioral and molecular mechanisms.

Erratum: A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives [Corrigendum].

Related Experiment Videos

Tuberculosis outbreak among Rastafarians in Birmingham

Related Concept Videos

Related Articles